UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$324M |
| 2 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$241M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$150M |
| 4 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$142M |
| 5 |
UBS Group
UBS
|
+$140M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI ACWI ETF
ACWI
|
+$630M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$608M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$368M |
| 4 |
Tesla
TSLA
|
+$339M |
| 5 |
Amazon
AMZN
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 53.09% |
| 2 | Technology | 10.88% |
| 3 | Financials | 6.69% |
| 4 | Healthcare | 6.54% |
| 5 | Consumer Discretionary | 4.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AZUL
9626
DELISTED
Azul
AZUL
| $2K | ﹤0.01% |
241
-3,387
| -93% | -$28.5K |
|
|
BARK.WS
9627
DELISTED
BARK Inc Warrants
BARK.WS
| $2K | ﹤0.01% |
7,167
-468
| -6% | -$96 |
|
9628
Heartbeam
BEAT
$22.7M
| $2K | ﹤0.01% |
+492
| New | +$784 |
|
9629
Biofrontera
BFRIW
| $2K | ﹤0.01% |
4,283
+430
| +11% | +$268 |
|
9630
BioVie
BIVI
$13.7M
| $2K | ﹤0.01% |
9
+6
| +200% | +$1.43K |
|
9631
BNY Mellon International Equity ETF
BKIE
$1.33B
| $2K | ﹤0.01% |
+87
| New | +$1.73K |
|
|
STEX
9632
Streamex Corp
STEX
$72M
| $2K | ﹤0.01% |
360
| – | – |
|
9633
BT Brands
BTBD
$11.1M
| $2K | ﹤0.01% |
+731
| New | +$1.68K |
|
|
BNC
9634
CEA Industries
BNC
$246M
| $2K | ﹤0.01% |
+187
| New | +$2.91K |
|
|
MBAI
9635
MBody AI Ltd. Ordinary Share
MBAI
$97.7M
| $2K | ﹤0.01% |
53
+46
| +657% | +$2.12K |
|
9636
Catalyst Bancorp
CLST
$73M
| $2K | ﹤0.01% |
173
-1,158
| -87% | -$15.3K |
|
9637
Cocrystal Pharma
COCP
$23.3M
| $2K | ﹤0.01% |
465
+348
| +297% | +$1.63K |
|
9638
Crawford & Co Class A
CRD.A
$588M
| $2K | ﹤0.01% |
386
-1,122
| -74% | -$7.49K |
|
|
CRDL
9639
Cardiol Therapeutics
CRDL
$228M
| $2K | ﹤0.01% |
2,000
-3,511
| -64% | -$4.28K |
|
9640
Creative Realities
CREX
$35.7M
| $2K | ﹤0.01% |
1,029
+1,028
| +102,800% | +$1.98K |
|
9641
Culp Inc
CULP
$46.2M
| $2K | ﹤0.01% |
434
+41
| +10% | +$194 |
|
9642
Cultivar ETF
CVAR
$45M
| $2K | ﹤0.01% |
88
| – | – |
|
|
DDL
9643
Dingdong
DDL
$499M
| $2K | ﹤0.01% |
702
-740
| -51% | -$3.5K |
|
9644
Dragonfly Energy
DFLI
$13.7M
| $2K | ﹤0.01% |
+2
| New | +$1.84K |
|
|
DMA
9645
Destra Multi-Alternative Fund
DMA
$67M
| $2K | ﹤0.01% |
342
-651
| -66% | -$4.59K |
|
9646
FT Vest US Equity Deep Buffer ETF March
DMAR
$466M
| $2K | ﹤0.01% |
+79
| New | +$2.41K |
|
|
DUO
9647
Fangdd Network Group
DUO
$21M
| $2K | ﹤0.01% |
+7
| New | +$3.18K |
|
9648
eHealth
EHTH
$28.5M
| $2K | ﹤0.01% |
565
-33,975
| -98% | -$237K |
|
9649
Entera Bio
ENTX
$512M
| $2K | ﹤0.01% |
1,754
-5,650
| -76% | -$8.53K |
|
9650
Epsilon Energy
EPSN
$184M
| $2K | ﹤0.01% |
369
-45
| -11% | -$293 |
|
Similar funds
UBS Group's Q3 2022 Portfolio in Review
As of Q3 2022, UBS Group held 11,885 positions worth $228B, down 6.3% from $244B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS Group withdrew a net $9.22B in Q3 2022, closing 1,023 positions and reducing 3,845 holdings. Its most notable exit was CMC Materials, Inc. Common Stock, an estimated $111M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 53% of assets, up from 50% a quarter earlier, followed by Technology and Financials.
Against the trend, UBS Group opened a new position in Fairlead Tactical Sector ETF worth $18.4M.
- UBS Group's largest Q3 2022 buy was Fairlead Tactical Sector ETF: 824,803 shares worth $18.4M.
- UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q3 2022, an estimated $324M increase.
- UBS Group's biggest Q3 2022 reduction was iShares MSCI ACWI ETF, cutting an estimated $630M.
- UBS Group fully exited CMC Materials, Inc. Common Stock in Q3 2022, selling an estimated $111M.
- UBS Group's ten largest holdings make up 14% of its $228B portfolio in Q3 2022.
- UBS Group opened 1,175 new positions and closed 1,023 in Q3 2022.
- UBS Group's portfolio value fell 6.3% quarter-over-quarter to $228B.
Based on UBS Group's 13F filing for Q3 2022, filed 10 Nov 2022.